Coronavirus Infections: all 952 studies

Page 1 of 10. Open to participants first (50), then studies with results posted, then the rest; newest registration first within each.

• A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing FormulationsNot yet recruitingNCT07863635Phase 4
• ELderly REspiratory VIral CohortNot yet recruitingNCT07813481
• A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in Participants ≥6 Months to <12 Years of AgeNot yet recruitingNCT07808697Phase 2
• A Study of COVID-19 Vaccine(s) in Children and AdultsRecruitingNCT07798648Phase 3
• A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of AgeRecruitingNCT07730450Phase 4
• A Safety, Reactogenicity and Immunogenicity Trial of RVX-sCPD9 Booster Intranasal COVID-19 VaccineNot yet recruitingNCT07703475Phase 1
• A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated AdultsRecruitingNCT07536308Phase 1
• A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely ImmunocompromisedRecruitingNCT07013474Phase 3
• Corona Virus Disease 2019 Cohort StudyRecruitingNCT06927622
• A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune ResponsesRecruitingNCT06810934Phase 1/2
• A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe DiseaseRecruitingNCT06679140Phase 3
• Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVIDRecruitingNCT06631287Phase 3
• A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine FormulationsRecruitingNCT06585241Phase 4
• Evaluation of Concordance Between Exhaled Air Test (eBAM-CoV) and RT-PCR to Detect SARS-CoV-2RecruitingNCT06099795Not applicable
• SA55 Novel Coronavirus Broad-spectrum Neutralizing Antibody Nasal Spray in Health PeopleRecruitingNCT06048393Phase 1
• Clinical Study of Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)Not yet recruitingNCT06025812Not applicable
• Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter StudyRecruitingNCT05868239Not applicable
• Next Generation T-cell Vaccine Against Coronavirus Disease (COVID-19)Not yet recruitingNCT05633446Phase 1/2
• Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental OxygenRecruitingNCT05624450Phase 3
• University Hospital of Ioannina COVID-19 (Coronavirus Disease 2019) RegistryRecruitingNCT05534074
• The Association of Gut Microbiota With COVID 19 Infection in ChildrenRecruitingNCT05303155
• Respiratory Virus Sampling and RepositoryRecruitingNCT05266222
• Clinical Study for Subjects With COVID-19 Using Allogeneic Adipose Tissue-Derived Mesenchymal Stem CellsNot yet recruitingNCT05017298Phase 2
• Observational Digital Biomarker Discovery in Respiratory Virus Challenge StudiesRecruitingNCT04772170
• Analysis of the Pathophysiology and Pathology of Coronavirus Disease 2019 (COVID-19), Including Chronic MorbidityRecruitingNCT04747366
• KIDney Injury in Times of COVID-19 (KIDCOV)Enrolling by invitationNCT04705766
• Expanded Access to Zofin for Patients With COVID-19AvailableNCT04657406
• COVID-19 in Baselland: Validation of Simple and Accurate Tests for COVID-19 Detection, Monitoring and Tracing (ACCURATE-BL-COVID-19)RecruitingNCT04625257
• Understanding Immunity to the Flu Vaccine in COVID-19 PatientsRecruitingNCT04579588
• Capturing MultiORgan Effects of COVID-19RecruitingNCT04510025
• SPI-1005 Treatment in Moderate COVID-19 PatientsEnrolling by invitationNCT04484025Phase 2
• Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After ConvalescenceRecruitingNCT04448145
• Study of the Incidence of SARS-CoV-2 Infection (COVID-19)RecruitingNCT04429594Not applicable
• The Natural History of Hospitalized COVID-19 PatientsRecruitingNCT04424992
• COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History StudyRecruitingNCT04391816
• Novel Regimens in COVID-19 TreatmentRecruitingNCT04382846Phase 3
• Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19RecruitingNCT04380870
• ARMOR Study: COVID-19 Seroprevalence Among Healthcare WorkersRecruitingNCT04367857
• Long-term Impact of Infection With Novel Coronavirus (COVID-19)RecruitingNCT04362150
• Impact of the Coronavirus (COVID-19) on Patients With CancerRecruitingNCT04330521
• In-depth Immunological Investigation of COVID-19.RecruitingNCT04327570
• ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 InfectionEnrolling by invitationNCT04326426Phase 3
• Risk Factors for Community- and Workplace Transmission of COVID-19RecruitingNCT04320732
• COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome PredictorRecruitingNCT04318366
• Eculizumab (Soliris) in Covid-19 Infected PatientsAvailableNCT04288713
• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)RecruitingNCT04278404
• Outcomes Mandate National Integration With Cannabis as MedicineRecruitingNCT03944447Phase 2
• Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT StudyRecruitingNCT03808922Phase 3
• Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?RecruitingNCT01904188
• Viral Infections in Healthy and Immunocompromised HostsRecruitingNCT01306084
• Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral InfectionTerminatedNCT06999603Phase 2Results posted
• Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)CompletedNCT06729606Phase 3Results posted
• Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)CompletedNCT06729593Phase 3Results posted
• Stellate Ganglion Block for COVID-induced ParosmiaCompletedNCT06253806Phase 2Results posted
• Safety Study of SLV213 for the Treatment of COVID-19.TerminatedNCT06146374Phase 1Results posted
• A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of AgeCompletedNCT06097273Phase 3Results posted
• A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy IndividualsCompletedNCT05997290Phase 2/3Results posted
• CDI-988 Safety Study in Healthy ParticipantsCompletedNCT05977140Phase 1Results posted
• A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy AdultsCompletedNCT05827926Phase 1/2Results posted
• A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19CompletedNCT05815498Phase 3Results posted
• International Sites: Novel Experimental COVID-19 Therapies Affecting Host ResponseTerminatedNCT05593770Phase 2/3Results posted
• Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273.214 SARS-CoV-2 (COVID-19) Vaccine in InfantsTerminatedNCT05584202Phase 2Results posted
• BERRY- a Study of Sambucol ® in the Treatment, and Reduction of Symptoms in Participants With Coronavirus 19CompletedNCT05489770Not applicableResults posted
• Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in AdultsCompletedNCT05463068Phase 3Results posted
• Assessing Safety of Coronavirus Infection (COVID-19) Messenger RNA (mRNA) Vaccine Administration in the Setting of a Previous Adverse ReactionCompletedNCT05212610Phase 4Results posted
• A Study to Evaluate the Safety and Tolerability of AZD7442 in Chinese AdultsCompletedNCT05184062Phase 2Results posted
• Efficacy of Oral Rinses for Inactivation of COVID-19 (MOR2)CompletedNCT05178173Not applicableResults posted
• A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Vaccine BoostersCompletedNCT05137236Phase 2Results posted
• COVID-19 Study to Evaluate Safety, Tolerability, and Efficacy of REGN14256+Imdevimab for the Treatment of COVID-19 Adult and Adolescent Patients Without Risk Factors for Progression to Severe DiseaseTerminatedNCT05081388Phase 1/2Results posted
• Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 PatientsTerminatedNCT05077969Phase 2Results posted
• A Study of Baricitinib (LY3009104) in Children With COVID-19TerminatedNCT05074420Phase 3Results posted
• A Trial Evaluating the Safety and Immunogenicity of 3 COVID-19 SARS-CoV-2 RNA Vaccines in Healthy AdultsCompletedNCT05037097Phase 1/2Results posted
• A Study of Ad26.COV2.S Administered as Booster Vaccination in Adults Who Have Previously Received Primary Vaccination With Ad26.COV2.S or BNT162b2CompletedNCT04999111Phase 2Results posted
• COVID-19 Administration of Single-Dose Subcutaneous Anti- Spike(s) SARS-CoV-2 Monoclonal Antibodies Casirivimab and Imdevimab in High-Risk Pediatric Participants Under 12 Years of AgeTerminatedNCT04992273Phase 2Results posted
• Study of Varespladib in Patients Hospitalized With Severe COVID-19TerminatedNCT04969991Phase 2Results posted
• To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age.CompletedNCT04955626Phase 3Results posted
• Study of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013)CompletedNCT04939428Phase 3Results posted
• Novel Experimental COVID-19 Therapies Affecting Host ResponseCompletedNCT04924660Phase 2/3Results posted
• Assessing the Mother-to-infant Transmission Capabilities of COVID-19 Infection Among Pregnant Women in Ontario, CanadaCompletedNCT04913948Results posted
• Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19).CompletedNCT04898166Results posted
• SARS-CoV-2 Human Challenge Characterisation StudyCompletedNCT04865237Not applicableResults posted
• A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory OutpatientsTerminatedNCT04847141Phase 3Results posted
• ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19CompletedNCT04843761Phase 3Results posted
• Effect of Respiratory Exerciser on Pulmonary Functions of COVID-19 PatientsCompletedNCT04826731Results posted
• Glucocorticoid Therapy in Coronavirus Disease COVID-19 PatientsTerminatedNCT04780581Phase 4Results posted
• Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19TerminatedNCT04778059Phase 2Results posted
• COVFIS-HOME: COVID-19 Pilot Study of Fisetin to Alleviate Dysfunction and Decrease ComplicationsCompletedNCT04771611Phase 2Results posted
• Antiviral Efficacy and Acceptability of Mouth Rinses for Inactivation of COVID-19TerminatedNCT04748783Phase 2Results posted
• Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19CompletedNCT04732949Phase 3Results posted
• Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living SettingsCompletedNCT04726371Not applicableResults posted
• Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19CompletedNCT04724720Phase 2Results posted
• N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19)CompletedNCT04706416Phase 1Results posted
• Understanding COVID-19 Infection in Pregnant Women and Their BabiesCompletedNCT04703270Results posted
• Cereset Research In Healthcare Workers During COVID-19CompletedNCT04682197Not applicableResults posted
• Double Blind, Placebo Controlled Study of Safety and Efficacy of Leronlimab in Patients With "Long" COVID-19CompletedNCT04678830Phase 2Results posted
• Community Collaboration to Combat COVID-19 (C-FORWARD)CompletedNCT04673292Not applicableResults posted
• A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy AdultsTerminatedNCT04668339Phase 2Results posted
• Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19)TerminatedNCT04668209Phase 2Results posted
• A Study of Auxora in Patients With Critical COVID-19 PneumoniaTerminatedNCT04661540Phase 2Results posted
• Camostat With Bicalutamide for COVID-19TerminatedNCT04652765Phase 1Results posted

← Coronavirus Infections overview